Lupin Limited has informed the Exchange regarding a press release dated March 25, 2023, titled “Lupin Announces Completion of Pharmacovigilance Inspectionby the U.S. FDA with No Observations.”…….
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
